The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria
Fecha
2020Autor
Dunachie, Susanna J
Day, Nicholas PJ
Dolecek, Christiane
Resumen
Estimating the contribution of antimicrobial resistance (AMR) to
global mortality and healthcare costs enables evaluation of
interventions, informs policy decisions on resource allocation,
and drives research priorities. However assembling the high
quality, patient-level data required for global estimates is
challenging. Capacity for accurate microbiology culture and
antimicrobial susceptibility testing is woefully neglected in low
and middle-income countries, and further surveillance and
research on community antimicrobial usage, bias in blood
culture sampling, and the contribution of co-morbidities such
as diabetes is essential. International collaboration between
governments, policy makers, academics, microbiologists,
front-line clinicians, veterinarians, the food and agriculture
industry and the public is critical to understand and tackle
AMR.
Palabras clave
Antimicrobial resistant bacteriaEnlace al recurso
https://doi.org/10.1016/j.mib.2020.09.013Colecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.